<code id='94A85224BF'></code><style id='94A85224BF'></style>
    • <acronym id='94A85224BF'></acronym>
      <center id='94A85224BF'><center id='94A85224BF'><tfoot id='94A85224BF'></tfoot></center><abbr id='94A85224BF'><dir id='94A85224BF'><tfoot id='94A85224BF'></tfoot><noframes id='94A85224BF'>

    • <optgroup id='94A85224BF'><strike id='94A85224BF'><sup id='94A85224BF'></sup></strike><code id='94A85224BF'></code></optgroup>
        1. <b id='94A85224BF'><label id='94A85224BF'><select id='94A85224BF'><dt id='94A85224BF'><span id='94A85224BF'></span></dt></select></label></b><u id='94A85224BF'></u>
          <i id='94A85224BF'><strike id='94A85224BF'><tt id='94A85224BF'><pre id='94A85224BF'></pre></tt></strike></i>

          leisure time

          leisure time

          author:hotspot    Page View:78
          Nasdaq
          Mario Tama/Getty Images

          Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

          The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

          advertisement

          The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Oral obesity drug from Viking Therapeutics hits key early target
          Oral obesity drug from Viking Therapeutics hits key early target

          DrewAngerer/GettyImagesVikingTherapeuticssaidTuesdaythatitscloselywatchedoralobesitydrughadsucceeded

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          The leaders of Italy and Poland say European Union should focus on stopping migration

          Poland'sPrimeMinisterMateuszMorawiecki,right,andItaly'sPrimeMinisterGiorgiaMelonispeakduringanewscon